Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Buy
52
TXRH Quote, Financials, Valuation and Earnings
Last price:
$172.15
Seasonality move
:
3.14%
Day range:
$166.27 - $169.61
52-week range:
$146.75 - $206.04
Dividend yield:
1.49%
P/E ratio:
26.11x
P/S ratio:
2.11x
P/B ratio:
8.26x
Volume:
900.6K
Avg. volume:
1.4M
1-year change:
8.87%
Market cap:
$11.2B
Revenue:
$5.4B
EPS (TTM):
$6.47
Analysts' Opinion
-
Consensus RatingTexas Roadhouse has received a consensus rating of Hold. The company's average rating is a Hold based on 11 Buy ratings, 17 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $191.57, Texas Roadhouse has an estimated upside of 13.41% from its current price of $168.92.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $139.78 representing 17.25% downside risk from its current price of $168.92.
Fair Value
-
According to the consensus of 28 analysts, Texas Roadhouse has 13.41% upside to fair value with a price target of $191.57 per share.
TXRH vs. S&P 500
-
Over the past 5 trading days, Texas Roadhouse has underperformed the S&P 500 by -3.82% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Texas Roadhouse does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Texas Roadhouse has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Texas Roadhouse reported revenues of $1.4B.
Earnings Growth
-
Texas Roadhouse has grown year-over-year earnings for 10 quarters straight. In the most recent quarter Texas Roadhouse reported earnings per share of $1.73.
Enterprise value:
11B
EV / Invested capital:
--
Price / LTM sales:
2.11x
EV / EBIT:
20.98x
EV / Revenue:
2.05x
PEG ratio (5yr expected):
0.61x
EV / Free cash flow:
27.54x
Price / Operating cash flow:
28.35x
Enterprise value / EBITDA:
15.66x
Gross Profit (TTM):
$947.3M
Return On Assets:
14.86%
Net Income Margin (TTM):
8.07%
Return On Equity:
34.11%
Return On Invested Capital:
34.11%
Operating Margin:
9.64%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $4B | $4.6B | $5.4B | $1.2B | $1.4B | |
| Gross Profit | $653.6M | $735.1M | $947.3M | $183.7M | $251.8M | |
| Operating Income | $327.1M | $359.9M | $523.9M | $83.9M | $138.6M | |
| EBITDA | $464.2M | $513.1M | $702.1M | $124.4M | $187.9M | |
| Diluted EPS | $3.97 | $4.53 | $6.47 | $1.08 | $1.73 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $510.7M | $563.5M | $396.8M | $356.5M | $516.6M | |
| Total Assets | $2.3B | $2.5B | $2.5B | $2.8B | $3.2B | |
| Current Liabilities | $506.3M | $602.1M | $652M | $745.4M | $828.1M | |
| Total Liabilities | $1.4B | $1.4B | $1.5B | $1.6B | $1.8B | |
| Total Equity | $943.1M | $1.1B | $1B | $1.2B | $1.4B | |
| Total Debt | $240M | $100M | $50M | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $511.7M | $565M | $753.6M | $174.2M | $237.5M | |
| Cash From Investing | -$263.7M | -$367.2M | -$336.9M | -$93.6M | -$99.7M | |
| Cash From Financing | -$409.8M | -$267.4M | -$275.7M | -$45.7M | -$81.8M | |
| Free Cash Flow | $265.6M | $218M | $399.3M | $71.1M | $129.7M | |
TXRH
Sector
Market Cap
$11.2B
$409.1M
Price % of 52-Week High
81.98%
68.72%
Dividend Yield
1.49%
0%
Shareholder Yield
2.16%
3.88%
1-Year Price Total Return
8.87%
-18.39%
Beta (5-Year)
0.878
0.833
Dividend yield:
1.49%
Annualized payout:
$2.44
Payout ratio:
37.56%
Growth streak:
4 years
Technicals
8-day SMA
Sell
Level
$172.52
200-day SMA
Sell
Level
$177.43
Bollinger Bands (100)
Sell
Level
173.47 - 192.75
Chaikin Money Flow
Buy
Level
76.5M
20-day SMA
Sell
Level
$174.10
Relative Strength Index (RSI14)
Sell
Level
42.97
ADX Line
Sell
Level
21.95
Williams %R
Neutral
Level
-65.5808
50-day SMA
Sell
Level
$176.20
MACD (12, 26)
Sell
Level
-1.79
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
108.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.6647)
Buy
CA Score
(Annual)
Level (0.6434)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.3325)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Texas Roadhouse Inc is a restaurant company operating predominately in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba’s 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roahouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.
Stock Forecast FAQ
In the current month, TXRH has received 11 Buy ratings 17 Hold ratings, and 0 Sell ratings. The TXRH average analyst price target in the past 3 months is $191.57.
-
Where Will Texas Roadhouse Stock Be In 1 Year?
According to analysts, the consensus estimate is that Texas Roadhouse share price will rise to $191.57 per share over the next 12 months.
-
What Do Analysts Say About Texas Roadhouse?
Analysts are divided on their view about Texas Roadhouse share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Texas Roadhouse is a Sell and believe this share price will drop from its current level to $139.78.
-
What Is Texas Roadhouse's Price Target?
The price target for Texas Roadhouse over the next 1-year time period is forecast to be $191.57 according to 28 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 17 analysts rate the stock a Hold.
-
Is TXRH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Texas Roadhouse is a Hold. 17 of 28 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TXRH?
You can purchase shares of Texas Roadhouse via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Texas Roadhouse shares.
-
What Is The Texas Roadhouse Share Price Today?
Texas Roadhouse was last trading at $172.15 per share. This represents the most recent stock quote for Texas Roadhouse. Yesterday, Texas Roadhouse closed at $168.92 per share.
-
How To Buy Texas Roadhouse Stock Online?
In order to purchase Texas Roadhouse stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
GATE alert for Apr 2
Marblegate Acquisition [GATE] is up 86.64% over the past day.
Buy
52
NUTX alert for Apr 2
Nutex Health [NUTX] is up 5.41% over the past day.
Buy
75
CORT alert for Apr 2
Corcept Therapeutics [CORT] is down 8.84% over the past day.
